Skip to main content
. Author manuscript; available in PMC: 2013 Mar 22.
Published in final edited form as: Prog Mol Biol Transl Sci. 2012;107:215–262. doi: 10.1016/B978-0-12-385883-2.00002-3

Fig. 7.

Fig. 7

Timeline of molecular and cellular pathologies in transgenic mice ubiquitously expressing SOD1G93A. The “symptomatic” stage denotes the period following initial onset of muscle weakness and wasting (80–100 days). Dates of pathology appearance taken from.44,91,114